Overview
Mark Roger Olsen, MD, is a board-certified, independent medical oncologist at Ascension St. John in Tulsa, Oklahoma. Dr. Olsen diagnoses and treats cancer using medications, such as chemotherapy, immunotherapy and targeted therapies. Every appointment with Dr. Olsen starts with a conversation. He takes the time to answer all your questions - big and small.
Dr. Olsen is highly rated in 62 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Astrocytoma, and Embryonal Tumor with Multilayered Rosettes.
Dr. Olsen is board certified in The American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 3 clinical trials. Dr. Olsen is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
12697 E 51st St, Tulsa, OK 74146
Additional Areas of Focus
Dr. Olsen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Oklahoma Cancer Specialist And Research Institute
Scott W. Cole, MD, is a board-certified, independent hematologist, oncologist and hospice/palliative medicine specialist at Ascension St. John in Tulsa, Oklahoma. Dr. Cole diagnoses and treats blood diseases and blood cancer. Every appointment with Dr. Cole starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Cole is highly rated in 89 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Cole is board certified in The American Board Of Internal Medicine - Hematology, The American Board Of Internal Medicine - Hospice And Palliative Medicine, and The American Board Of Internal Medicine - Medical Oncology. Dr. Cole is currently accepting new patients.
Oklahoma Cancer Specialist And Research Institute
Ali H. Moussa, MD, is a board-certified, independent oncologist with Ascension St. John in Tulsa, Oklahoma. Dr. Moussa diagnoses and treats cancer using medications, such as chemotherapy, immunotherapy and targeted therapies. Every appointment with Dr. Moussa starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Moussa is highly rated in 115 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Moussa is board certified in The American Board Of Internal Medicine - Internal Medicine and The American Board Of Internal Medicine - Medical Oncology. Dr. Moussa is currently accepting new patients.
Oklahoma Cancer Specialist And Research Institute
Charles W. Taylor, MD, is an independent medical oncologist at Ascension St. John in Tulsa, Oklahoma. Dr. Taylor diagnoses and treats cancer using medications, such as chemotherapy. Every appointment with Dr. Taylor starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Taylor is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Taylor is board certified in The American Board Of Internal Medicine - Internal Medicine and The American Board Of Internal Medicine - Medical Oncology. Dr. Taylor is currently accepting new patients.
Frequently Asked Questions about Dr. Mark R. Olsen
How do I make an appointment with Dr. Mark R. Olsen?
You can book an appointment with Dr. Mark R. Olsen by calling their office at 918-505-3200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark R. Olsen a top-rated expert for Familial Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark R. Olsen is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark R. Olsen specialize in?
While Dr. Mark R. Olsen is a Oncology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mark R. Olsen participate in research or clinical trials?
Yes. Dr. Mark R. Olsen has published 9 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Mark R. Olsen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark R. Olsen accept my insurance?
Dr. Mark R. Olsen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 918-505-3200 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaDr. Olsen isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Olsen isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Colorectal CancerDr. Olsen isDistinguished. Learn about Colorectal Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Familial Colorectal CancerDr. Olsen isDistinguished. Learn about Familial Colorectal Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Advanced
- Acute Megakaryoblastic LeukemiaDr. Olsen isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Adult Immune ThrombocytopeniaDr. Olsen isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Olsen isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Olsen isAdvanced. Learn about Agranulocytosis.
- AngiosarcomaDr. Olsen isAdvanced. Learn about Angiosarcoma.
- Bone TumorDr. Olsen isAdvanced. Learn about Bone Tumor.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Olsen isExperienced. Learn about Acute Myeloid Leukemia (AML).
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Olsen isExperienced. Learn about Alveolar Soft Part Sarcoma.